RNAi & miRNA

Date: Thursday, 19 April 2012 - Friday, 20 April 2012
Location: Boston, USA

Keynote Speakers

Reuven Agami
Head of Division / Group Leader, The Netherlands Cancer Institute

Gunter Meister
Professor, University of Regensburg

Overview

Welcome to the RNAi & miRNA track of the Genomics Research conference and exhibition. This year's event will be held in Boston.

This conference will detail the cutting edge research taking place in the two fields with a particular emphasis on the complex roles microRNA play in cancer and their regulation. The latest developments in both therapeutics and delivery of RNAi based medicines will also be discussed to help map out the commercial trends occurring in this field. Other conference tracks at this event include Advances in qPCR, Epigenetics, Next-Gen Sequencing, and Genomic Biomarkers

Other conference tracks at this event include Advances in qPCR, Epigenetics, Next-Gen Sequencing, and Genomic Biomarkers. Registered delegates will have access to all eight meetings ensuring a very cost-effective trip.

In addition the event will also host a cutting edge training course which can be viewed here and two business tutorials which can be viewed here.

Agenda Topics

Delivery Techniques
miRNA Biology
miRNAs in Cancer
RNAi and miRNA Therapeutics

Sponsorship and Exhibition Opportunities

Exhibition Team,
exhibitors@selectbio.com
+44 (0) 1206 501654

Confirmed Speakers to date

Mark Behlke, Vice President/Chief Scientific Officer, Integrated DNA Technologies Inc
Bhavneet Bhinder, Bioinformatics Engineer, Memorial Sloan Kettering Cancer Center
Karen Bulock, Associate Director/Vice President, RXi Pharmaceuticals
Alex Chenchik, President/CSO, Cellecta Inc
Christopher Cheng, Postdoctoral Fellow, Yale University
Sven Diederichs, Group Leader, University Of Heidelberg
Kan Ding, Professor, The National Center for Drug Screening
Scott Eliasof, Vice President, Cerulean Pharma Inc
Aurora Esquela Kerscher, Assistant Professor, Eastern Virginia Medical School
Anja Hoeg, Associate Director of Discovery, Santaris Pharma
Anthony Leung, Assistant Professor, Johns Hopkins Bloomberg School of Public Health
Michael McManus, Assistant Professor, University of California San Francisco
Andrew Miller, Professor, Kings College London
Peter Mouritzen, Vice President, Exiqon A/S
Dan Peer, Head, Tel Aviv University
Alexander Pertsemlidis, Associate Professor, The University of Texas Health Science Center at San Antonio
Enal Razvi, Managing Director, Select Biosciences Inc
Anthony Saleh, IRTA scientist, NIDCD/NIH
Xianbin Yang, Director, AM Biotechnologies LLC